13Indexed trials
mesh condition
Myasthenia Gravis
Intelligence
Myasthenia Gravis intelligence: 13 indexed trials, 6 recruiting studies, 13 sponsors across 29 countries.
6Recruiting
13Sponsors
29Countries
Leading sponsors
Beth Israel Deaconess Medical Center10 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Fredrik Piehl10 recruiting
HealthPartners Institute11 recruiting
Hoffmann-La Roche10 recruiting
Kite, A Gilead Company11 recruiting
Ming-Hsing Chang10 recruiting
Novartis Pharmaceuticals11 recruiting
Sanford Health11 recruiting
Sanofi10 recruiting
Tianjin Medical University General Hospital11 recruiting
University of California, Davis10 recruiting
Geographic activity
United States10trials
Canada5trials
Australia5trials
Poland4trials
China4trials
Spain4trials
Italy4trials
Taiwan3trials
United Kingdom3trials
Germany3trials
France3trials
Japan3trials
Leading interventions
BAFF-R CART1trials
Blood Draw1trials
Cheek swab1trials
Current standard discharge educational intervention1trials
Cyclophosphamide1trials
Efgartigimod PH20 SC1trials
Fludarabine1trials
KITE-3631trials
Light Intensity Exercise1trials
Moderate Intensity Exercise1trials
Personalized discharge educational intervention1trials
Psychological counseling intervention1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.